Substituted hydrochromenopyridines
US6326377A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2000 |
| Grant date | Dec 4, 2001 |
| Priority date | — |
| Expiry date | Jan 10, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I): ##STR1## wherein: PA1 m is 0 to 3 inclusive, PA1 n is 0 to 3 and 2.ltoreq.m+n.ltoreq.3, PA1 p is 1 to 6 inclusive, PA1 X represents cyano or --CO--NR.sub.4 R.sub.5, R.sub.4 and R.sub.5 being selected from hydrogen, linear or branched (C.sub.1 -C.sub.6)-alkyl, (C.sub.3 -C.sub.7)-cycloalkyl,and aryl, PA1 R.sub.1 and R.sub.2 each independently represent hydrogen or linear or branched (C.sub.1 -C.sub.6)-alkyl, PA1 R.sub.3 represents hydrogen, optionally substituted phenyl, naphthyl or heteroaryl, or aryloxy or arylthio, or aryl or heteroaryl substituted by A'--Cy, A' and Cy being as defined in the description, and medicinal products containing the same which are useful as D.sub.3 receptor ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.